The Europe lyophilized injectable market is expected to grow from US$ 808.34 million in 2022 to US$ 1,108.45 million by 2028. It is estimated to grow at a CAGR of 5.4% from 2022 to 2028.
Increasing Demand for Contract Research Manufacturing Services
Freeze drying, or lyophilization, is a drying process that consists of the sublimation of ice crystals into vapor. Lyophilization is a process based on negative temperatures and the product's activity and stability. Moreover, in this process, active ingredients are better retained while limiting any damage to the product and avoiding any degradation of the molecules. Thus, freeze-drying is especially popular in pharmaceutical and diagnostic sectors. The increased quality and extended shelf life of lyophilized injectable drugs are creating opportunities to implement the lyophilization process in product manufacturing. Contract manufacturing and research services are in huge demand, delivering lyophilized injectable drugs to offer high-quality products to end users. Moreover, many pharmaceutical companies are refocusing on their core capabilities, such as research and development, leading to divestments of in-house manufacturing capacities, which is growing the demand for contract research and manufacturing services (CRAMs) for manufacturing. Furthermore, CRAMs play crucial roles in providing additional capacities to mitigate the risk of supply shortages by offering additional sites for pharmaceutical companies with multisite supply strategies and backup capacities. Furthermore, safe transit, extended pharmaceutical storage life, and many other advantages offered by lyophilized injectables are increasing the adoption of the lyophilization technique by many enterprises across the region.Market Overview
EuropeLyophilized Injectable Market Segmentation
The Europe lyophilized injectable marketis segmented based on type of packaging, type of delivery, indication, end user, and country.- Based on type of packaging, the Europe lyophilized injectable market is segmented into single-use vials, point-of-care reconstitution, and specialty packaging. The single-use vials segment held the largest market share in 2022.
- Based on indication, the Europe lyophilized injectable market is segmented into metabolic and oncology conditions, infectious diseases, autoimmune diseases, and others. The metabolic and oncology conditions segment held the largest market share in 2022.
- Based on end user, the Europe lyophilized injectable market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. The hospitals segment held the largest market share in 2022.
- Based on country, the Europe lyophilized injectable market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the market in 2022.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Lyophilized Injectable Market - By Type of Packaging
1.3.2 Europe Lyophilized Injectable Market - By Type of Delivery
1.3.3 Europe Lyophilized Injectable Market - By Indication
1.3.4 Europe Lyophilized Injectable Market - By End User
1.3.5 Europe Lyophilized Injectable Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Lyophilized Injectable Market - Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Lyophilized Injectable Market- Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Demand for Contract Research Manufacturing Services
5.1.2 Increasing Demand of Biologics
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Expansion of Pipeline of Lyophilized Injectable Drugs
5.4 Future Trends
5.4.1 Advancement in Lyophilized Packaging
5.5 Impact Analysis
6. Lyophilized Injectable Market- Europe Analysis
6.1 Europe Lyophilized Injectable Market Revenue Forecast and Analysis
7. Europe Lyophilized Injectable Market Analysis - By Type of Packaging
7.1 Overview
7.2 Europe Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)
7.3 Single-use vials
7.3.1 Overview
7.3.2 Single-use vials: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Point-of-Care Reconstitution
7.4.1 Overview
7.4.2 Point-of-Care Reconstitution: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Specialty Packaging
7.5.1 Overview
7.5.2 Specialty Packaging: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8. Europe Lyophilized Injectable Market Analysis - By Type of Delivery
8.1 Overview
8.2 Europe Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)
8.3 Prefilled Diluent Syringes
8.3.1 Overview
8.3.2 Prefilled Diluent Syringes: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Single Step Devices
8.4.1 Overview
8.4.2 Single Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Proprietary Reconstitution Devices
8.5.1 Overview
8.5.2 Proprietary Reconstitution Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Multi-Step Devices
8.6.1 Overview
8.6.2 Multi-Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9. Europe Lyophilized Injectable Market Analysis - By Indication
9.1 Overview
9.2 Europe Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)
9.3 Metabolic and Oncology Conditions
9.3.1 Overview
9.3.2 Metabolic and Oncology Conditions: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Infectious Diseases
9.4.1 Overview
9.4.2 Infectious Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Autoimmune Diseases
9.5.1 Overview
9.5.2 Autoimmune Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Other Indications
9.6.1 Overview
9.6.2 Other Indications: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10. Europe Lyophilized Injectable Market Analysis - By End User
10.1 Overview
10.2 Europe Lyophilized Injectable Market, by End User, 2021 and 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Specialty Clinics
10.5.1 Overview
10.5.2 Specialty Clinics: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10.6 Other End Users
10.6.1 Overview
10.6.2 Other End Users: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
11. Europe Lyophilized Injectable Market - Country Analysis
11.1 Overview
11.1.1 Europe: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
11.1.1.1 Germany: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.1.1 Overview
11.1.1.1.1 Germany: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.1.2 Germany: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ ‘Million)
11.1.1.1.3 Germany: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ ‘Million)
11.1.1.1.4 Germany: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ ‘Million)
11.1.1.1.5 Germany: Lyophilized Injectable Market, by End User, 2019-2028 (US$ ‘Million)
11.1.1.2 UK: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.2.1 Overview
11.1.1.2.2 UK: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.2.3 UK: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ ‘Million)
11.1.1.2.4 UK: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ ‘Million)
11.1.1.2.5 UK: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ ‘Million)
11.1.1.2.6 UK: Lyophilized Injectable Market, by End User, 2019-2028 (US$ ‘Million)
11.1.1.3 France: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.3.1 Overview
11.1.1.3.2 France: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.3.3 France: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ ‘Million)
11.1.1.3.4 France: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ ‘Million)
11.1.1.3.5 France: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ ‘Million)
11.1.1.3.6 France: Lyophilized Injectable Market, by End User, 2019-2028 (US$ ‘Million)
11.1.1.4 Italy: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.4.1 Overview
11.1.1.4.2 Italy: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.4.3 Italy: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ ‘Million)
11.1.1.4.4 Italy: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ ‘Million)
11.1.1.4.5 Italy: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ ‘Million)
11.1.1.4.6 Italy: Lyophilized Injectable Market, by End User, 2019-2028 (US$ ‘Million)
11.1.1.5 Spain: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.5.1 Overview
11.1.1.5.2 Spain: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.5.3 Spain: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ ‘Million)
11.1.1.5.4 Spain: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ ‘Million)
11.1.1.5.5 Spain: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ ‘Million)
11.1.1.5.6 Spain: Lyophilized Injectable Market, by End User, 2019-2028 (US$ ‘Million)
11.1.1.6 Rest of Europe: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.6.1 Overview
11.1.1.6.2 Rest of Europe: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.6.3 Rest of Europe: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ ‘Million)
11.1.1.6.4 Rest of Europe: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ ‘Million)
11.1.1.6.5 Rest of Europe: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ ‘Million)
11.1.1.6.6 Rest of Europe: Lyophilized Injectable Market, by End User, 2019-2028 (US$ ‘Million)
12. Industry Landscape
12.1 Overview
12.2 Inorganic Growth Strategies
12.2.1 Overview
12.3 Organic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 Baxter
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Nipro
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Curia Global, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Recipharm AB
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Vetter Pharma
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Jubilant HollisterStier (Jubilant Pharma Limited)
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Aristopharma Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 CordenPharma International
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Credence MedSystems, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 S.G. Biopharm Pvt. Ltd.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
List of Tables
Table 1. Europe Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ ‘Million)
Table 3. Germany: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ ‘Million)
Table 4. Germany: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 5. Germany: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ ‘Million)
Table 6. UK: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ ‘Million)
Table 7. UK: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ ‘Million)
Table 8. UK: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 9. UK: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ ‘Million)
Table 10. France: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ ‘Million)
Table 11. France: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ ‘Million)
Table 12. France: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 13. France: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ ‘Million)
Table 14. Italy: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ ‘Million)
Table 15. Italy: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ ‘Million)
Table 16. Italy: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 17. Italy: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ ‘Million)
Table 18. Spain: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ ‘Million)
Table 19. Spain: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ ‘Million)
Table 20. Spain: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 21. Spain: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ ‘Million)
Table 22. Rest of Europe: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ ‘Million)
Table 23. Rest of Europe: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ ‘Million)
Table 24. Rest of Europe: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 25. Rest of Europe: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ ‘Million)
Table 26. Recent Inorganic Growth Strategies
Table 27. Recent Organic Growth Strategies
Table 28. Glossary of Terms
List of Figures
Figure 1. Europe Lyophilized Injectable Market Segmentation
Figure 2. Europe Lyophilized Injectable Market - By Country
Figure 3. Europe Lyophilized Injectable Market Overview
Figure 4. Europe Lyophilized Injectable Market, By Type of Packaging
Figure 5. Europe Lyophilized Injectable Market, By Country
Figure 6. Europe: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Europe Lyophilized Injectable Market Impact Analysis of Drivers and Restraints
Figure 9. Europe Lyophilized Injectable Market- Revenue Forecast and Analysis
Figure 10. Europe Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)
Figure 11. Europe Single-use vials: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Europe Point-of-Care Reconstitution: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe Specialty Packaging: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)
Figure 15. Europe Prefilled Diluent Syringes: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe Single Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Europe Proprietary Reconstitution Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe Multi-Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Europe Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)
Figure 20. Europe Metabolic and Oncology Conditions: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe Infectious Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Europe Autoimmune Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Europe Other Indications: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Europe Lyophilized Injectable Market, by End User, 2021 and 2028 (%)
Figure 25. Europe Hospitals: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Europe Ambulatory Surgical Centers: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Europe Specialty Clinics: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Europe Other End Users: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Europe: Lyophilized Injectable Market, by Key Country - Revenue (2021) (US$ ‘Million)
Figure 30. Europe: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
Figure 31. Germany: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 32. UK: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 33. France: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 34. Italy: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 35. Spain: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 36. Rest of Europe: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aristopharma Ltd.
- Baxter
- CordenPharma International
- Credence MedSystems, Inc.
- Curia Global, Inc.
- Jubilant HollisterStier (Jubilant Pharma Limited)
- Nipro
- Recipharm AB
- S.G. Biopharm Pvt. Ltd.
- Vetter Pharma
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 141 |
| Published | December 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 808.34 Million |
| Forecasted Market Value ( USD | $ 1108.45 Million |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Europe |
